Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $0.54.

  • Anaptysbio's EPS (Basic) rose 14736.84% to $0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.74, marking a year-over-year increase of 5493.42%. This contributed to the annual value of -$5.12 for FY2024, which is 1583.86% up from last year.
  • Per Anaptysbio's latest filing, its EPS (Basic) stood at $0.54 for Q3 2025, which was up 14736.84% from -$1.34 recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's EPS (Basic) registered a high of $0.54 during Q3 2025, and its lowest value of -$1.71 during Q2 2024.
  • Over the past 5 years, Anaptysbio's median EPS (Basic) value was -$1.19 (recorded in 2021), while the average stood at -$1.05.
  • As far as peak fluctuations go, Anaptysbio's EPS (Basic) crashed by 724257.58% in 2022, and later surged by 14736.84% in 2025.
  • Over the past 5 years, Anaptysbio's EPS (Basic) (Quarter) stood at -$1.19 in 2021, then surged by 33.96% to -$0.79 in 2022, then crashed by 102.32% to -$1.59 in 2023, then surged by 51.73% to -$0.77 in 2024, then surged by 170.36% to $0.54 in 2025.
  • Its last three reported values are $0.54 in Q3 2025, -$1.34 for Q2 2025, and -$1.28 during Q1 2025.